Lumiera Health Past Earnings Performance

Past criteria checks 0/6

Lumiera Health has been growing earnings at an average annual rate of 3%, while the Pharmaceuticals industry saw earnings growing at 46% annually. Revenues have been declining at an average rate of 30.8% per year.

Key information

3.0%

Earnings growth rate

22.4%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate-30.8%
Return on equityn/a
Net Margin-398.2%
Last Earnings Update31 Aug 2023

Recent past performance updates

Recent updates

Have Insiders Been Buying Lumiera Health Inc. (CVE:NHP) Shares?

Feb 16
Have Insiders Been Buying Lumiera Health Inc. (CVE:NHP) Shares?

Revenue & Expenses Breakdown

How Lumiera Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:NHP.H Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Aug 230-210
31 May 230-210
28 Feb 231-210
30 Nov 221-310
31 Aug 221-220
31 May 221-120
28 Feb 221-120
30 Nov 211-120
31 Aug 210-220
31 May 211-210
28 Feb 210-310
30 Nov 201-210
31 Aug 200-210
31 May 200-220
29 Feb 200-220
30 Nov 190-220
31 Aug 191-210
31 May 191-210
28 Feb 191-210
30 Nov 181-110
31 Aug 181010
31 May 180010
28 Feb 180000
30 Nov 170000
30 Nov 160000

Quality Earnings: NHP.H is currently unprofitable.

Growing Profit Margin: NHP.H is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if NHP.H's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare NHP.H's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NHP.H is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (-40.8%).


Return on Equity

High ROE: NHP.H's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/10/12 12:28
End of Day Share Price 2024/07/15 00:00
Earnings2023/08/31
Annual Earnings2022/11/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Lumiera Health Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution